%A HOU Jing, REN Zhijing, WEI Na, et al %T HER-2 promotes breast cancer cell epithelial-mesenchymal transition by regulating ZEB1 %0 Journal Article %D 2016 %J China Oncology %R 10.19401/j.cnki.1007-3639.2016.12.002 %P 968-973 %V 26 %N 12 %U {http://www.china-oncology.com/CN/abstract/article_752.shtml} %8 2016-12-30 %X Background and purpose: Human epidermal growth factor receptor-2 (HER-2), a member of epidermal growth factor receptor family, initiates a diverse set of signaling pathways that ultimately affect such fundamental processes as cell proliferation, cell motility and cell apoptosis. It is reported that HER-2 was associated with epithelial-mesenchymal transition (EMT) process. However, the mechanism needs further investigation. The purpose of this study was to investigate the mechanism of HER-2 on regulating EMT process. Methods: Transwell assay was used to determine the motility of breast cancer cells; Real-time fluorescence quantitative polymerase chain reaction (RTFQ- PCR) was employed to determine the expression of genes of interest, and reactive oxygen species production was measured by reactive oxygen species detection kit. Results: HER-2 overexpression in breast cancer cells could promote cell migration and invasion. Mechanistic study showed that HER-2 overexpression could upregulate ZEB1 expression. ZEB1 silencing by siRNA reduced cell motility of HER-2-overexpressing breast cancer cells. Furthermore, reactive oxygen species produced in HER-2-overexpressing breast cancer cells were less than those produced in corresponding control cells. Conclusion: Our study demonstrated that HER-2 overexpression endowed breast cancer cells with EMT related properties by upregulating ZEB1 expression. ZEB1 could be a candidate target for further study of the relationship between HER-2 and EMT.